The panel of WHO Guideline Development Group has recommended the treatment combining casirivimab and imdevimab for the two specific groups of patients with COVID-19.
source https://www.jagranjosh.com/current-affairs/who-recommends-antibody-treatment-for-critical-covid-patients-check-details-1632478937-1